High-Intensity Focused Ultrasound (HIFU) is an advanced non-invasive treatment technology that selectively destroys prostate cancer tissue using precisely focused ultrasound energy. It is particularly suitable for early-stage localized prostate cancer. Clinical studies have demonstrated that HIFU achieves comparable therapeutic outcomes to conventional surgery, while better preserving urinary and sexual function.
HIFU focuses ultrasound energy through an external probe to generate temperatures of 65°C or higher within the targeted area, causing immediate coagulative necrosis of cancer cells. The entire procedure is guided and monitored in real-time using ultrasound/ MRI fusion imaging, ensuring precision and safety.
*Remarks: Specific treatment plans must be determined by a urologist based on individual cases